Terrance Mcguire Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 13 hours ago
Terrance Mcguire has an estimated net worth of at least $29.1 million*, as of yesterday. They own 10.9 million shares of ALEC stock. They have sold 612,389 shares of ALEC stock since 2021, for an estimated $3.0 million.
Terrance Mcguire $ALEC SEC Form 4 Insider Trading
Terrance Mcguire has filed a total of 1 insider trades in $ALEC since 2021. Their most recent trade was a sale of 500,000 shares, made on Sep 11, 2023. Their largest trade was a sale of 500,000 shares, made on Sep 11, 2023. We estimate that they now own 10.9 million shares of $ALEC, worth an estimated $26.1 million.
Insider Trading at $ALEC
There have been a total of 103 insider trades reported at $ALEC since 2021, with 0 shares purchased and 3.0 million shares sold. The most active insider traders in $ALEC stock have been Arnon Rosenthal, Robert Paul, and Gary Romano. The most recent trade was a sale of 16,489 shares reported by MARC GRASSO (Chief Financial Officer), made on Dec 02, 2024.
History of Insider Stock Trades by Terrance Mcguire
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
IVVD | Sale | 112,381 | May 29, 2024 | May 31, 2024, 5:09 p.m. |
ALEC | Sale | 500,000 | Sep 11, 2023 | Sept. 13, 2023, 4:29 p.m. |
CYCN | Sale | 8 | Aug 09, 2023 | Aug. 11, 2023, 4:25 p.m. |
ADGI | Purchase | 267,769 | Aug 10, 2021 | Aug. 11, 2021, 8 p.m. |
ADGI | Purchase | 5,219 | Aug 10, 2021 | Aug. 11, 2021, 8 p.m. |
ADGI | Purchase | 1,834 | Aug 10, 2021 | Aug. 11, 2021, 8 p.m. |
ADGI | Purchase | 2,678 | Aug 10, 2021 | Aug. 11, 2021, 8 p.m. |
ADGI | Purchase | 45,000 | Aug 10, 2021 | Aug. 11, 2021, 8 p.m. |
ADGI | Purchase | 177,500 | Aug 10, 2021 | Aug. 11, 2021, 8 p.m. |
CYCN | Purchase | 92,831 | Jun 03, 2021 | June 6, 2021, 8 p.m. |
CYCN | Purchase | 3,322 | Jun 03, 2021 | June 6, 2021, 8 p.m. |
$ALEC Executives and Stock Owners with Insider Trades
-
Arnon Rosenthal, Chief Executive Officer
-
Robert Paul, Chief Medical Officer
-
Gary Romano, Chief Medical Officer
-
Marc Grasso, Chief Financial Officer
-
Shehnaaz Suliman, President and COO
-
Sara Kenkare-Mitra, President and Head of R&D
-
Robert King, Chief Development Officer
-
Calvin Yu, Vice President, Finance
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.